Dr.Charanjith Kumar Sehgal Opposition, Tezacaftor, (3140/Kolnp/2012)
No Annotations
Alert me when there are new annotations for this document
10 similar patent oppositions
-
Cipla Ltd. opposition, sunitinib (su) , (IN/PCT/2002/00785/DEL )
Countries: India Date: 2012
-
Delhi Network of Positive People (DNP+) opposition, tenofovir disoproxil fumarate tenofovir disoproxil fumarate (TDF) , (1135/DEL/2007 (divisional to 896/DEL/2002))
Countries: India Date: 2012
-
Lupin Ltd. opposition, Teneligliptin, (3176/KOLNP/2007)
Countries: India Date: 2012
-
Fresenius Kabi Oncology Limited opposition, Enzalutamide, (9668/DELNP/2007 (WO2006/124118))
Countries: India Date: 2012
-
Merck, Novartis, Crucell Holand, Dr.Franz-Josef and Strawman opposition, Pneumococcal Conjugate Vaccine, (EP 1868645)
Countries: India Date: 2012
-
Natco Pharma Ltd. opposition, Dasatinib , (4309/DELNP/2006)
Countries: India Date: 2012
-
Indian Pharmaceutical Alliance opposition, Elsulfavirine, (1576/CHENP/2011)
Countries: India Date: 2012
-
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Bedaquiline Long Acting Formulation, (IN202017005443)
Countries: India Date: 2021
-
Cancer Patient Aid Association (CPAA) opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021
-
Entrepreneurship Development Center opposition, Molnupiravir, (201717025098)
Countries: India Date: 2021